Terms: = Kidney tumors AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
6 results:
1. Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma.
Wang Y; Ji H; Zhu B; Xing Q; Xie H
Eur J Immunol; 2023 Jan; 53(1):e2250105. PubMed ID: 36367018
[TBL] [Abstract] [Full Text] [Related]
2. Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.
Tamukong PK; Kuhlmann P; You S; Su S; Wang Y; Yoon S; Gong J; Figlin RA; Janes JL; Freedland SJ; Halabi S; Small EJ; Rini BI; Kim HL
Urol Oncol; 2022 Nov; 40(11):495.e1-495.e10. PubMed ID: 35973929
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.
Zeng X; Chen K; Li L; Tian J; Ruan W; Hu Z; Peng D; Chen Z
Free Radic Biol Med; 2022 May; 184():135-147. PubMed ID: 35381326
[TBL] [Abstract] [Full Text] [Related]
4. Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules.
Wang Z; Li K; Chen W; Wang X; Huang Y; Wang W; Wu W; Cai Z; Huang W
Cell Mol Life Sci; 2020 Sep; 77(17):3441-3452. PubMed ID: 31838573
[TBL] [Abstract] [Full Text] [Related]
5. ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer.
Chen K; Yu G; Gumireddy K; Li A; Yao W; Gao L; Chen S; Hao J; Wang J; Huang Q; Xu H; Ye Z
Oncotarget; 2015 Mar; 6(9):6959-76. PubMed ID: 25749518
[TBL] [Abstract] [Full Text] [Related]
6. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
Pawlus MR; Wang L; Hu CJ
Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
[TBL] [Abstract] [Full Text] [Related]